Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor

Expression Profiling of Liposarcoma Yields a Multigene Predictor of Patient Outcome and Identifies Genes That Contribute to Liposarcomagenesis

(2011) R. M. Gobble et al.   CANCER RESEARCH

DNA topoisomerase II-? as a proliferation marker in human gliomas: correlation with PCNA expression and patient survival

(2011) H. Zhao et al.   CLINICAL NEUROPATHOLOGY

Resveratrol induces DNA double-strand breaks through human topoisomerase II interaction

(2010) Stefano Leone et al.   CANCER LETTERS

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas

(2008) A. Desjardins et al.   CLINICAL CANCER RESEARCH

Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity

(2008) Monika E. Hegi et al.   JOURNAL OF CLINICAL ONCOLOGY

Distinct roles of Topoisomerase II isoforms: DNA damage accelerating α, double strand break repair promoting β

(2007) Raj Kumar Mandraju et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS